HPR97 National Reimbursement Drug List Negotiation in China: Analysis of the Key Trends and Factors Influencing the Value Appraisal and Price Determination

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1227
https://www.valueinhealthjournal.com/article/S1098-3015(22)03432-5/fulltext
Title : HPR97 National Reimbursement Drug List Negotiation in China: Analysis of the Key Trends and Factors Influencing the Value Appraisal and Price Determination
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03432-5&doi=10.1016/j.jval.2022.09.1227
First page :
Section Title :
Open access? : No
Section Order : 10772
Categories :
Tags :
Regions :
ViH Article Tags :